LifeStream, founded in 1951, proudly maintains affiliations with leading organizations in the North American blood banking industry. Through serious, consistent dialogue and professional consultation, we continually strive for new opportunities, a superior customer service model, and excellence in supporting our partner hospitals and the patients they serve.
America’s Blood Centers (ABC) is a North American-based network of community blood centers that collectively operate more than 600 fixed-site donor centers and supply more than 3,500 hospitals and medical facilities with the gift of blood. ABC members subscribe to a community-based blood banking philosophy;
donors know their gift stays in the community to help loved ones, friends, neighbors and colleagues. In times of local emergency or severe regional needs that strains supply, fellow ABC members collaborate to assist fellow members in need.
AABB is an international association of blood banks, including hospital and community blood centers, transfusion and transplantation services and individuals involved in activities related to transfusion and transplantation medicine. AABB supports high standards of medical, technical and administrative performance, scientific investigation, clinical application and education. It is dedicated to encouraging the voluntary donation of blood and other tissues and organs through education, public information and research.
LifeStream takes an active role in supporting economic growth and community strength for areas we serve through memberships in local chambers of commerce and economic vitality organizations, including the Inland Empire Economic Partnership (IEEP) and Coachella Valley Economic Partnership. (CVEP). Dr. Rick Axelrod, LifeStream’s president and CEO, is on the Board of Directors and an officer for CVEP and on the Board of Directors for Desert Regional Medical Center.
Clinical Laboratory Improvement Amendment (CLIA) (cms.gov)
The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). The objective of the CLIA program is to ensure quality laboratory testing. In total, CLIA covers approximately 254,000 laboratory entities.